Carole Ho
2019
In 2019, Carole Ho earned a total compensation of $2.5M as Chief Medical Officer at Denali Therapeutics, a 37% decrease compared to previous year.
Compensation breakdown
| Bonus | $176,000 |
|---|---|
| Option Awards | $1,558,941 |
| Salary | $440,000 |
| Stock Awards | $305,830 |
| Other | $8,800 |
| Total | $2,489,571 |
Ho received $1.6M in option awards, accounting for 63% of the total pay in 2019.
Ho also received $176K in bonus, $440K in salary, $305.8K in stock awards and $8.8K in other compensation.
Rankings
In 2019, Carole Ho's compensation ranked 4,875th out of 13,971 executives tracked by ExecPay. In other words, Ho earned more than 65.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,875 out of 13,971 | 65th |
Division Manufacturing | 1,820 out of 5,701 | 68th |
Major group Chemicals And Allied Products | 633 out of 2,200 | 71st |
Industry group Drugs | 533 out of 1,886 | 72nd |
Industry Biological Products, Except Diagnostic Substances | 119 out of 389 | 69th |
Source: SEC filing on April 22, 2020.
Ho's colleagues
We found three more compensation records of executives who worked with Carole Ho at Denali Therapeutics in 2019.
News
Denali Therapeutics CEO Ryan Watts' 2021 pay jumps 36% to $13M
April 19, 2022
Denali Therapeutics CEO Ryan Watts' 2020 pay jumps 87% to $9.3M
April 22, 2021
Denali Therapeutics CEO Ryan Watts' 2019 pay slips 17% to $5M
April 22, 2020
Denali Therapeutics CEO Ryan Watts' 2018 pay jumps 338% to $6M
April 18, 2019